The Impact of Probiotic Bacteria on the Efficacy of Anti-retroviral Therapy and Recurrence of Bacterial Vaginosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01258556|
Recruitment Status : Completed
First Posted : December 13, 2010
Last Update Posted : December 13, 2010
|Condition or disease||Intervention/treatment||Phase|
|Bacterial Vaginosis||Dietary Supplement: Yogurt supplemented with L. rhamnosus fiti Dietary Supplement: Yogurt not supplemented with a probiotic strain.||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Study Start Date :||June 2010|
|Actual Primary Completion Date :||July 2010|
|Experimental: Probiotic yogurt||
Dietary Supplement: Yogurt supplemented with L. rhamnosus fiti
200 ml of L. rhamnosus fiti at 10*9 cfu/ml daily for 30 days.
|Placebo Comparator: Placebo yogurt.||
Dietary Supplement: Yogurt not supplemented with a probiotic strain.
200 ml yoghurt without L. rhamnosus fiti daily for 30 days.
- Vaginal microbiota of HIV patients. [ Time Frame: 30 days ]
- Bacterial vaginosis. [ Time Frame: 30 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01258556
|Sekou-Toure Regional Hospital|
|Principal Investigator:||Nicodemus Butamanya, MD||Sekou-Toure Regional Hospital|